|8.55||+0.03 / +0.35%|
Data as of 3:59pm ET
|8.55||-0.0017 / -0.02%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 18.50, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +116.37% increase from the last price of 8.55.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.